244 related articles for article (PubMed ID: 24136889)
1. Identification of RASAL1 as a major tumor suppressor gene in thyroid cancer.
Liu D; Yang C; Bojdani E; Murugan AK; Xing M
J Natl Cancer Inst; 2013 Nov; 105(21):1617-27. PubMed ID: 24136889
[TBL] [Abstract][Full Text] [Related]
2. Germline alterations in RASAL1 in Cowden syndrome patients presenting with follicular thyroid cancer and in individuals with apparently sporadic epithelial thyroid cancer.
Ngeow J; Ni Y; Tohme R; Song Chen F; Bebek G; Eng C
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1316-21. PubMed ID: 24712574
[TBL] [Abstract][Full Text] [Related]
3. RASAL1 in thyroid cancer: wisdom from an old foe.
Ngeow J; Eng C
J Natl Cancer Inst; 2013 Nov; 105(21):1597-9. PubMed ID: 24136888
[No Abstract] [Full Text] [Related]
4. Association of PTEN gene methylation with genetic alterations in the phosphatidylinositol 3-kinase/AKT signaling pathway in thyroid tumors.
Hou P; Ji M; Xing M
Cancer; 2008 Nov; 113(9):2440-7. PubMed ID: 18831514
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations in the phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer.
Xing M
Thyroid; 2010 Jul; 20(7):697-706. PubMed ID: 20578891
[TBL] [Abstract][Full Text] [Related]
6. RASAL1 in thyroid cancer: promise from a new friend.
Xing M
J Clin Endocrinol Metab; 2014 Oct; 99(10):3619-21. PubMed ID: 25226296
[No Abstract] [Full Text] [Related]
7. Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma.
Wang HM; Huang YW; Huang JS; Wang CH; Kok VC; Hung CM; Chen HM; Tzen CY
Ann Surg Oncol; 2007 Oct; 14(10):3011-8. PubMed ID: 17638058
[TBL] [Abstract][Full Text] [Related]
8. Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers.
Liu Z; Hou P; Ji M; Guan H; Studeman K; Jensen K; Vasko V; El-Naggar AK; Xing M
J Clin Endocrinol Metab; 2008 Aug; 93(8):3106-16. PubMed ID: 18492751
[TBL] [Abstract][Full Text] [Related]
9. Molecular perspectives in differentiated thyroid cancer.
Buffet C; Groussin L
Ann Endocrinol (Paris); 2015 Feb; 76(1 Suppl 1):1S8-15. PubMed ID: 26826484
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancer.
Santarpia L; El-Naggar AK; Cote GJ; Myers JN; Sherman SI
J Clin Endocrinol Metab; 2008 Jan; 93(1):278-84. PubMed ID: 17989125
[TBL] [Abstract][Full Text] [Related]
11. Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer.
Hou P; Liu D; Shan Y; Hu S; Studeman K; Condouris S; Wang Y; Trink A; El-Naggar AK; Tallini G; Vasko V; Xing M
Clin Cancer Res; 2007 Feb; 13(4):1161-70. PubMed ID: 17317825
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression.
Ohta M; Seto M; Ijichi H; Miyabayashi K; Kudo Y; Mohri D; Asaoka Y; Tada M; Tanaka Y; Ikenoue T; Kanai F; Kawabe T; Omata M
Gastroenterology; 2009 Jan; 136(1):206-16. PubMed ID: 18992247
[TBL] [Abstract][Full Text] [Related]
13. High prevalence and mutual exclusivity of genetic alterations in the phosphatidylinositol-3-kinase/akt pathway in thyroid tumors.
Wang Y; Hou P; Yu H; Wang W; Ji M; Zhao S; Yan S; Sun X; Liu D; Shi B; Zhu G; Condouris S; Xing M
J Clin Endocrinol Metab; 2007 Jun; 92(6):2387-90. PubMed ID: 17426084
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylation and clinicopathological significance of RASAL1 gene in gastric cancer.
Chen H; Pan Y; Cheng ZY; Wang Z; Liu Y; Zhao ZJ; Fan H
Asian Pac J Cancer Prev; 2013; 14(11):6261-5. PubMed ID: 24377515
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma.
Santarpia L; Myers JN; Sherman SI; Trimarchi F; Clayman GL; El-Naggar AK
Cancer; 2010 Jun; 116(12):2974-83. PubMed ID: 20564403
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of RAS protein activator like-1 in gastric cancer.
Seto M; Ohta M; Ikenoue T; Sugimoto T; Asaoka Y; Tada M; Mohri D; Kudo Y; Ijichi H; Tateishi K; Otsuka M; Hirata Y; Maeda S; Koike K; Omata M
Int J Cancer; 2011 Mar; 128(6):1293-302. PubMed ID: 20473946
[TBL] [Abstract][Full Text] [Related]
17. Danhong Injection Alleviates Cardiac Fibrosis via Preventing the Hypermethylation of Rasal1 and Rassf1 in TAC Mice.
Li S; Li P; Liu W; Shang J; Qiu S; Li X; Liu W; Shi H; Zhou M; Liu H
Oxid Med Cell Longev; 2020; 2020():3158108. PubMed ID: 33456666
[TBL] [Abstract][Full Text] [Related]
18. TBX1 Functions as a Tumor Suppressor in Thyroid Cancer Through Inhibiting the Activities of the PI3K/AKT and MAPK/ERK Pathways.
Wang N; Li Y; Wei J; Pu J; Liu R; Yang Q; Guan H; Shi B; Hou P; Ji M
Thyroid; 2019 Mar; 29(3):378-394. PubMed ID: 30543152
[TBL] [Abstract][Full Text] [Related]
19. Genomic Alterations of Anaplastic Thyroid Carcinoma Detected by Targeted Massive Parallel Sequencing in a BRAF(V600E) Mutation-Prevalent Area.
Jeon MJ; Chun SM; Kim D; Kwon H; Jang EK; Kim TY; Kim WB; Shong YK; Jang SJ; Song DE; Kim WG
Thyroid; 2016 May; 26(5):683-90. PubMed ID: 26980298
[TBL] [Abstract][Full Text] [Related]
20. Lack of mutations in the thyroid hormone receptor (TR) alpha and beta genes but frequent hypermethylation of the TRbeta gene in differentiated thyroid tumors.
Joseph B; Ji M; Liu D; Hou P; Xing M
J Clin Endocrinol Metab; 2007 Dec; 92(12):4766-70. PubMed ID: 17911173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
